AR134053A1 - Proceso para elaborar baloxavir marboxil - Google Patents
Proceso para elaborar baloxavir marboxilInfo
- Publication number
- AR134053A1 AR134053A1 ARP240102713A ARP240102713A AR134053A1 AR 134053 A1 AR134053 A1 AR 134053A1 AR P240102713 A ARP240102713 A AR P240102713A AR P240102713 A ARP240102713 A AR P240102713A AR 134053 A1 AR134053 A1 AR 134053A1
- Authority
- AR
- Argentina
- Prior art keywords
- baloxavir
- manufacturing
- marboxyl
- icm
- implementation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Animal Behavior & Ethology (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
Abstract
La invención se refiere a un proceso novedoso para elaborar baloxavir marboxil (1) y baloxavir (1a), así como también a una implementación de elaboración continua integrada (ICM) de estos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP23201730 | 2023-10-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR134053A1 true AR134053A1 (es) | 2025-11-26 |
Family
ID=88291225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP240102713A AR134053A1 (es) | 2023-10-05 | 2024-10-04 | Proceso para elaborar baloxavir marboxil |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4788681A2 (es) |
| KR (1) | KR20260085417A (es) |
| CN (1) | CN121925422A (es) |
| AR (1) | AR134053A1 (es) |
| AU (1) | AU2024355785A1 (es) |
| IL (1) | IL327495A (es) |
| TW (1) | TW202530224A (es) |
| WO (1) | WO2025073819A2 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121127476A (zh) * | 2024-03-18 | 2025-12-12 | 石药集团中奇制药技术(石家庄)有限公司 | 多环吡啶酮衍生物及其用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107709321A (zh) | 2015-04-28 | 2018-02-16 | 盐野义制药株式会社 | 经取代的多环性吡啶酮衍生物及其前药 |
| US11261198B2 (en) | 2016-06-20 | 2022-03-01 | Shionogi & Co., Ltd. | Process for preparing substituted polycyclic pyridone derivative and crystal thereof |
-
2024
- 2024-10-03 EP EP24786060.4A patent/EP4788681A2/en active Pending
- 2024-10-03 WO PCT/EP2024/077821 patent/WO2025073819A2/en not_active Ceased
- 2024-10-03 KR KR1020267011224A patent/KR20260085417A/ko active Pending
- 2024-10-03 AU AU2024355785A patent/AU2024355785A1/en active Pending
- 2024-10-03 IL IL327495A patent/IL327495A/en unknown
- 2024-10-03 CN CN202480062823.9A patent/CN121925422A/zh active Pending
- 2024-10-04 AR ARP240102713A patent/AR134053A1/es unknown
- 2024-10-04 TW TW113137757A patent/TW202530224A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025073819A3 (en) | 2025-05-15 |
| CN121925422A (zh) | 2026-04-24 |
| TW202530224A (zh) | 2025-08-01 |
| IL327495A (en) | 2026-05-01 |
| WO2025073819A2 (en) | 2025-04-10 |
| EP4788681A2 (en) | 2026-08-12 |
| AU2024355785A1 (en) | 2026-03-26 |
| KR20260085417A (ko) | 2026-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108917T1 (el) | Ετερο υποκατεστημενοι αναστολεις διαυλου νατριου | |
| MX2019011758A (es) | Composicion para producir tagatosa y procedimiento de produccion de tagatosa usando la misma. | |
| MX2019011730A (es) | Composicion para producir tagatosa y procedimiento de produccion de tagatosa usando la misma. | |
| MX2023010695A (es) | Compuestos anti-virales. | |
| MX2020012627A (es) | Metodo para la produccion de compuestos monoterpenoides. | |
| MX2023014629A (es) | Nuevas formas solidas de (3r)-n-[2-ciano-4-fluoro-3-(3-metil-4-oxo -quinazolin-6-il)oxi-fenil]-3-fluoro-pirrolidin-1-sulfonamida. | |
| MX2023002291A (es) | Métodos y usos en la producción de composiciones estables que comprenden peróxidos y especies de cloro libre disponible. | |
| MX2024009760A (es) | Proceso para preparar compuestos de silicio organico. | |
| CL2023001148A1 (es) | Inductor de haploides dobles | |
| CL2024003302A1 (es) | Oligonucleótidos antisentido syf2. | |
| AR040719A1 (es) | Proceso para la produccion de una proteina heterologa | |
| IL279168B (en) | A process for the preparation of eribulin | |
| CO2024015096A2 (es) | Proceso mejorado para la fabricación de osimertinib | |
| AR125115A1 (es) | PROCEDIMIENTO PARA LA DETERMINACIÓN CUANTITATIVA DE Al₄C₃, ASÍ COMO DISPOSITIVO PARA LA REALIZACIÓN DEL PROCEDIMIENTO | |
| CL2022001248A1 (es) | Método para la producción de arn bicatenario | |
| WO2025073819A3 (en) | Process for manufacturing baloxavir marboxil | |
| CL2024003050A1 (es) | Método e intermediario para la preparación de apalutamida. | |
| MX2022003879A (es) | Proceso para elaborar acidos alcansulfonicos. | |
| EA202192840A1 (ru) | Способ получения соединений карбамоилоксиметилтриазолциклогексиловой кислоты | |
| EP4592765A4 (en) | PROCESSING CARTRIDGE | |
| EP4140982C0 (en) | PROCESSES AND INTERMEDIATES FOR THE PREPARATIONS OF CARBOPROST AND CARBOPROST TROMETHAMINE, AND CARBOPROST TROMETHAMINE PREPARED THEREFROM | |
| CR20240090A (es) | Proceso para la preparación de adrenomedulina pegilada, sus intermediarios y su uso | |
| MX2024005336A (es) | Composiciones y metodos para la modulacion de inmunidad mediada por cadena beta. | |
| JP1798243S (ja) | 宝飾品 | |
| JP1798244S (ja) | 宝飾品 |